Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.
Michael U CallaghanElina AsikaniusMichaela LehleJohannes OldenburgJohnny MahlanguMarianne UguenSammy ChebonRebecca Kruse-JarresVíctor Jiménez-YusteMidori ShimaPeter TraskChristine L KemptonCraig M KesslerGallia G LevyFlora PeyvandiPublished in: Research and practice in thrombosis and haemostasis (2022)
A significant proportion of bleeding events are untreated in people with hemophilia A. There is a need to further understand why bleeds remain untreated and to capture such events in clinical studies.
Keyphrases